Cargando…

Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study

BACKGROUND: The aim of the current study was to determine mast cell infiltration in malignant melanoma by immunohistochemistry method and its relationship with some of the cancer prognostic factors, including age, sex, and depth of the tumor. MATERIALS AND METHODS: In this retrospective analytic cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajabi, Parvin, Bagheri, Azam, Hani, Mohssen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414406/
https://www.ncbi.nlm.nih.gov/pubmed/28503494
http://dx.doi.org/10.4103/2277-9175.204592
_version_ 1783233371168571392
author Rajabi, Parvin
Bagheri, Azam
Hani, Mohssen
author_facet Rajabi, Parvin
Bagheri, Azam
Hani, Mohssen
author_sort Rajabi, Parvin
collection PubMed
description BACKGROUND: The aim of the current study was to determine mast cell infiltration in malignant melanoma by immunohistochemistry method and its relationship with some of the cancer prognostic factors, including age, sex, and depth of the tumor. MATERIALS AND METHODS: In this retrospective analytic cross-sectional study, paraffin-embedded tissue blocks of patients with cutaneous malignant melanoma who had undergone excisional biopsy were studied. Mast cells count in studied cases in different stages of the tumor depth was evaluated by mast cell tryptase immunohistochemistry method. Mast cells infiltration was evaluated both inside the tumor and peritumoral area. Tumor infiltrating lymphocytes (TILs) was also determined. Distribution of intratumoral and peritumoral mast cells and TILs was compared in different stages tof tumor depth. RESULTS: In this study, 51 cases with melanoma were studied. Mean ± standard deviation (SD) of intratumoral mast cells in stages 1, 2, and 3 was 9.4 ± 4.2, 10.8 ± 5.1, and 2.1 ± 2.3, respectively (P = 0.000). Mean ± SD of peritumoral mast cells in stages 1, 2 and 3 was 13.4 ± 2.4, 16.6 ± 2.4 and 8.2 ± 4.6, respectively (P = 0.000). There was a significant direct relationship between depth of the tumor and TIL (P = 0.000) and distribution of intratumoral (P = 0.000) and peritumoral mast cells (P = 0.000). CONCLUSION: Lower distribution of intratumoral and peritumoral mast cells and TILs in higher stages of tumor depth in malignant melanoma suggests a possible inhibitory effect of infiltrating mast cells and lymphocytes on the progression of this tumor.
format Online
Article
Text
id pubmed-5414406
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-54144062017-05-12 Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study Rajabi, Parvin Bagheri, Azam Hani, Mohssen Adv Biomed Res Original Article BACKGROUND: The aim of the current study was to determine mast cell infiltration in malignant melanoma by immunohistochemistry method and its relationship with some of the cancer prognostic factors, including age, sex, and depth of the tumor. MATERIALS AND METHODS: In this retrospective analytic cross-sectional study, paraffin-embedded tissue blocks of patients with cutaneous malignant melanoma who had undergone excisional biopsy were studied. Mast cells count in studied cases in different stages of the tumor depth was evaluated by mast cell tryptase immunohistochemistry method. Mast cells infiltration was evaluated both inside the tumor and peritumoral area. Tumor infiltrating lymphocytes (TILs) was also determined. Distribution of intratumoral and peritumoral mast cells and TILs was compared in different stages tof tumor depth. RESULTS: In this study, 51 cases with melanoma were studied. Mean ± standard deviation (SD) of intratumoral mast cells in stages 1, 2, and 3 was 9.4 ± 4.2, 10.8 ± 5.1, and 2.1 ± 2.3, respectively (P = 0.000). Mean ± SD of peritumoral mast cells in stages 1, 2 and 3 was 13.4 ± 2.4, 16.6 ± 2.4 and 8.2 ± 4.6, respectively (P = 0.000). There was a significant direct relationship between depth of the tumor and TIL (P = 0.000) and distribution of intratumoral (P = 0.000) and peritumoral mast cells (P = 0.000). CONCLUSION: Lower distribution of intratumoral and peritumoral mast cells and TILs in higher stages of tumor depth in malignant melanoma suggests a possible inhibitory effect of infiltrating mast cells and lymphocytes on the progression of this tumor. Medknow Publications & Media Pvt Ltd 2017-04-17 /pmc/articles/PMC5414406/ /pubmed/28503494 http://dx.doi.org/10.4103/2277-9175.204592 Text en Copyright: © 2017 Advanced Biomedical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Rajabi, Parvin
Bagheri, Azam
Hani, Mohssen
Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study
title Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study
title_full Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study
title_fullStr Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study
title_full_unstemmed Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study
title_short Intratumoral and Peritumoral Mast Cells in Malignant Melanoma: An Immunohistochemical Study
title_sort intratumoral and peritumoral mast cells in malignant melanoma: an immunohistochemical study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414406/
https://www.ncbi.nlm.nih.gov/pubmed/28503494
http://dx.doi.org/10.4103/2277-9175.204592
work_keys_str_mv AT rajabiparvin intratumoralandperitumoralmastcellsinmalignantmelanomaanimmunohistochemicalstudy
AT bagheriazam intratumoralandperitumoralmastcellsinmalignantmelanomaanimmunohistochemicalstudy
AT hanimohssen intratumoralandperitumoralmastcellsinmalignantmelanomaanimmunohistochemicalstudy